Clinical Trials Browser

Phase 3 × Completed × Thrombocytopenia × Clear all

NCT03471078 2023-09-28

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Phase 3 Completed

122 enrolled 19 charts

Classical hematology

Thrombocytopenia

NCT01663441 2020-09-16

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Phase 3 Completed

Classical hematology

Thrombocytopenia

NCT02389621 2018-10-30

L-PLUS 2

Phase 3 Completed

215 enrolled 24 charts 1 FDA

Classical hematology

Thrombocytopenia

NCT01444417 2017-02-09

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Phase 3 Completed

62 enrolled 16 charts 1 FDA

Classical hematology

Purpura, Thrombocytopenic, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic

NCT00039910 2007-05-04

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Phase 3 Completed

Classical hematologyLymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Thrombocytopenia

NCT00151866 2007-02-27

Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma

Phase 3 Completed

Classical hematology

Thrombocytopenia, Transfusion Reaction

NCT00037791 2006-11-09

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Phase 3 Completed

Classical hematologyLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Neoplasms, Thrombocytopenia